Translational Development Acquisition TDAC
Shell Companies, Financial Services
$10.83
+0.09%
- Market cap
- $209.1M
- Revenue, 12 months
- n/m
- not a meaningful number
Charts
Financials
| Income statement | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|
| SG&A | $0 | $1.7K | $61.3K | $133.4K | $347.4K | $221.1K+13023% | $213.7K+249% | $162.3K+22% | $281.2K−19% | $661K+199% |
| $0 | −$1.7K | −$61.3K | −$133.4K | −$347.4K | −$221.1K+13023% | −$213.7K+249% | −$162.3K+22% | −$281.2K−19% | −$661K+199% | |
| Net income | $0 | −$1.7K | −$61.3K | −$8K | $1.5M | $1.6M | $1.7M | $1.6M | $1.3M−10% | $947K−42% |
| $0.00 | $0.00 | −$0.02 | n/a | $0.07 | $0.07 | $0.08 | n/a | $0.06−14% | $0.04−43% | |
| 4M | 4M | 4M | n/a | 4.7M+15% | 4.7M+15% | 4.7M+15% | n/a | 4.7M+0% | 4.7M+0% |
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Peers
Companies in Financial Services nearest Translational Development Acquisition's size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| TDACTranslational Development Acquisition | $209.1M | n/m | n/a | n/m | n/m | n/m | |
| DHXDHI | $207.6M | 159× | 31.6× | 1.7× | −7% | 1.0% | |
| CBFVCB Financial Services | $203.8M | 29.1× | 13.9× | n/m | −6% | 14.9% | |
| FCAPFirst Capital | $214.6M | 11.6× | 12.7× | n/m | +18% | 33.8% | |
| RBKBRhinebeck Bancorp | $202.3M | 14.4× | 10.1× | n/m | +60% | 18.4% | |
| CPSSConsumer Portfolio Services | $218.7M | 9.8× | 6.1× | 0.5× | +10% | 5.0% | |
| MRBKMeridian | $221.5M | 10.1× | 8.4× | n/m | +7% | 16.6% | |
| LARKLandmark Bancorp | $197.4M | 10.0× | 8.8× | n/m | +14% | 26.9% | |
| GBFHGBank Financial | $222.4M | 12.0× | 19.2× | n/m | +20% | 22.4% | |
| SBFGSB Financial | $196.5M | 11.8× | 10.1× | n/m | +10% | 24.5% | |
| FNWDFinward Bancorp | $192.5M | 19.6× | 10.7× | n/m | +9% | 14.2% | |
| Peer median | $205.7M | 11.9× | 10.4× | 1.1× | +10% | 17.5% |
More on Translational Development Acquisition
Each number over time
Its groups
About
- Industry
- Shell Companies
- Sector
- Financial Services
Valuation data, not investment advice. Prices as of .